Thesis subject: uterine carcinosarcomas.Uterine carcinosarcomas or malignant mixed Muller tumors are rare and aggressive tumors, with poor prognosis, and represent less than 5% of all malignant tumors of the uterine body.These tumors are twice as frequent in black patients as in white ones. Purpose: This study aims to specify the epidemiological characteristics of our patients, to identify the diagnostic problem, clinical as well as radiological, and discuss the therapeutic management. Material And Methods: This is a retrospective study of nine cases of patients who were treated between 2013 and 2016 at the Department of Gynecologyand Obstetrics 1 at Hassan University Hospital Center 2. Results : The average age of our patients ranges from 50 to 80 years with an average age of 65 years. Of the nine patients, 95% are large multiparous, and all are menopausal. All our patients consulted for postmenopausal metrorrhagia with pelvicpain. Paraclinically, we performed a pelvic ultrasound in all patients, whose resultswere in favor of an increase in the size of the uterus, with the presence in endocavity of a heterogeneous echogenic image that invades the myometrium in places. A pelvic MRI showed in the nine cases, a voluminous endo-uterine process, with heterogeneous enhancement after contrast. The patients benefited from adiagnostic hysteroscopy with biopsy that favored a uterine carcinosarcoma. All ourpatients received surgical treatment, except for 2 patients who were found be inoperable and sent for radiotherapy. The pathological analysis was in favor of amalignant mixed malignant tumor associating carcinoma and endometrial stromalsarcoma with invasion of more than 50 of the my ometrium. In the nine cases, fivepatients were referred oncology, to receive chemotherapy and radiotherapy, a patient was scheduled postoperatively for chemotherapy, but died twenty days after the intervention. The other patients have been lost. Conclusion: Uterine carcinosarcomas are rare aggressive tumors that have been the subject of little study. First-line treatment will be surgical. Adjuvant chemotherapy has shown interest in this type of tumor. The place of radiotherapy remains to be discussed.
Introduction: Lhydatidose sevit a letat endemique au Maroc, sa localisation pelvi genitale est rare et trompeuse. Elle est due au developpement chez lHomme de larves de cestodes du genre Echinococcusgranulosus. Patientes et methodes: Nous rapportons les cas des deuxpatientes operees pour des masses abdominopelvienne avec decouverte per operatoire des kystesperitoneales dont lanapath en faveur dhydatidosepelvien. Discussion : La localisationpelviennedu kyste hydatique est rare. Elle varie entre 0,30 % et 4,27 % des localisations hydatiques selon les auteurs.Le mode de contamination hydatique de la region pelvienne demeure hypothetique la contamination est habituellement secondaire a la rupture intra-abdominale dun kyste hydatique hepatique. La symptomatologie peut etre vague et deroutante, telle que desmetrorragies ou une sterilite. Le diagnostic peut etre pose fortuitement lors de la cesarienne ou lors dune grossesse compliquee, un travail dystocique ou une hemorragie des suites de couche. Le traitement des kystes hydatiques est chirurgical. La voie dabord doit etre large, la sterilisation du kyste et la protection des champs operatoires est assuree par des solutions scolicides leau oxygenee est la plus utilisee. Il est recommande de faire une kystectomie ou une peri-kystectomie des kystes accessibles et sans danger et une kystectomie partielle pour les kystes profonds et au contact avec leselements vasculaires. Le traitement medical est peu efficace il est indique en cas de contre-indication operatoire ou en cas de localisations multiples ou si la resection est incomplete. Conclusion: Bien que rare, le diagnostic de kyste hydatique pelvien doit etre evoque devant toute malade presentant une masseabdominopelvienne. La kystectomie est le traitement de choix. Le traitement medical peut etre utilise en deuxieme intention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.